Gift 5 articles to anyone you choose each month when you subscribe. The country’s two largest superannuation funds are pushing the federal government to expand its performance test to cover retirement ...
Using a new skin care product without testing it first can potentially cause allergic contact dermatitis, an inflammatory skin condition in which the immune system overreacts to an ingredient in the ...
Sept 2 (Reuters) - OpenAI said on Tuesday it will acquire Statsig in an all-stock deal valuing the product testing startup at about $1.1 billion based on OpenAI's current valuation of $300 billion.
OpenAI has agreed to buy Bellevue-based product testing startup Statsig for $1.1 billion in an all-stock deal, the company said, marking one of the largest acquisitions in the ChatGPT maker’s history.
There’s a lot of play-acting in fashion, and it extends beyond “types” into materiality. This is especially true in menswear, where over the past few years work- and activewear have become trendy.
Launching a product is never just about the product. As I write this, my two-and-a-half-year-old company, Hugimals World, is preparing to roll out Hugarounds—a new line of warmable weighted plushies ...
David leads the Hardware team at CNET, covering phones, wearables, laptops, TVs, streaming, future tech and more. We provide helpful, expert reviews, advice and videos on what to buy and how to get ...
In today’s fast-paced digital landscape, where user expectations are constantly evolving and competition is only a click away, building successful products is no longer about guesswork or intuition—it ...
Albert Invent is a digital platform that uses AI-driven analysis to assist chemists with research. The platform integrates data from electronic lab notebooks to speed up product development. This ...
In the rapidly evolving 2025 consumer packaged goods (CPG) landscape, where market pressures demand faster, smarter decision making, breakthrough innovations don’t happen in isolation. They succeed in ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results